Medpace Holdings, Inc.
MEDP Healthcare Diagnostics & Research
Medpace Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 20.0% from fiscal 2024.
- Revenue
- +8.50%
- EPS
- +24.6%
- Free cash flow
- −16.6%
Quarter to September 2026, against a year earlier
Follow MEDP
Alert me
Medpace Holdings, Inc. (MEDP) Operating cash flow
Medpace Holdings, Inc.'s operating cash flow for fiscal 2025 was $713.2M, up 17.1% from $608.8M in fiscal 2024. Over the twelve months to 30 September 2026 it was $723.0M. Over the past ten years it has ranged from $85.9M (fiscal 2015) to $713.2M (fiscal 2025) — the current reading is the highest in ten years. Operating cash flow has risen for 10 consecutive fiscal years. Medpace Holdings, Inc. ranks 11th of 49 Diagnostics & Research companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $713.2M | 17.15% |
| FY2024 | $608.8M | 40.48% |
| FY2023 | $433.4M | 11.68% |
| FY2022 | $388.1M | 47.36% |
| FY2021 | $263.3M | 1.80% |
| FY2020 | $258.7M | 28.14% |
| FY2019 | $201.9M | 28.92% |
| FY2018 | $156.6M | 60.79% |
| FY2017 | $97.4M | 6.16% |
| FY2016 | $91.7M | 6.83% |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | $216.6M | 33.69% |
| Jun 2026 | $162.0M | 6.74% |
| Mar 2026 | $151.8M | (21.21%) |
| Dec 2025 | $192.7M | (21.75%) |
| 41 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| DGX Quest Diagnostics Incorporated compare | $2.0B |
| LH Labcorp Holdings Inc. compare | $1.8B |
| ILMN Illumina, Inc. compare | $1.2B |
| ICLR ICON PLC compare | $1.0B |
| MEDP Medpace Holdings, Inc. | $723.0M |
| RVTY Revvity Inc. compare | $655.8M |
| QGEN QIAGEN N.V. compare | $654.5M |
| CRL Charles River Laboratories International, Inc. compare | $622.4M |
| GH Guardant Health, Inc. compare | −$173.5M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on MEDP
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement